What are the treatments for vertigo?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Treatments for Vertigo Vertigo can be effectively managed with canalith repositioning procedures, such as the Epley maneuver 1, which has been shown to be highly effective in treating benign paroxysmal positional vertigo (BPPV).

  • Canalith Repositioning Procedure (CRP): This procedure involves a series of head movements designed to move free-floating particles in the inner ear back into the vestibule, relieving vertigo symptoms 1.
  • Liberatory Maneuver (LM): Also known as the Semont maneuver, this procedure uses inertial and gravity forces to move particles in the inner ear and relieve vertigo symptoms 1.
  • Vestibular Rehabilitation: This type of therapy can help improve balance and reduce vertigo symptoms in some patients 1.
  • Observation: In some cases, observation with follow-up may be recommended as initial management for patients with BPPV 1. It's essential to note that vestibular suppressant medications, such as antihistamines and benzodiazepines, are not recommended for routine treatment of BPPV 1. Instead, these medications may be used to alleviate nausea and vomiting associated with vertigo, but their use should be limited to a short duration due to potential side effects. Key Considerations
  • Patients should be educated about the impact of BPPV on their safety and the potential for disease recurrence 1.
  • Clinicians should assess patients with BPPV for factors that modify management, including impaired mobility or balance, central nervous system disorders, and increased risk for falling 1.
  • The role of patient preferences in making decisions about treatment should be considered, taking into account factors such as absolute benefits, adverse effects, and cost of treatment 1.

From the FDA Drug Label

Meclizine hydrochloride tablets are indicated for the treatment of vertigo associated with diseases affecting the vestibular system in adults (1). Recommended dosage: 25 mg to 100 mg daily, in divided doses (2.1).

The treatment for vertigo is meclizine hydrochloride tablets, with a recommended dosage of 25 mg to 100 mg daily, in divided doses 2.

  • The dosage can be administered in divided doses.
  • Meclizine hydrochloride tablets are specifically indicated for the treatment of vertigo associated with diseases affecting the vestibular system in adults 2 2.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.